Abstract:In spite of all the scientific and technical advances in recent years, shock that is not rapidly correctable with fluid can have a morbidity rate exceeding 80%. Consequently awareness of such precipitating factors as sepsis and early diagnosis and treatment are essential. Treatment should be rapid and should follow a previously outlined protocol. Such protocols should include correction of the precipitating problem and aggressive resuscitation to assure adequate ventilation and oxygenation of the blood and optimal oxygen delivery to the tissues. Fluid and blood should be given as needed until filling pressures begin to rise rapidly with further fluid infusion. With hemorrhagic shock in previously healthy individuals, a hemoglobin level of 10.0 g/dL is usually adequate. In older, septic, or cardiogenic shock patients, a hemoglobin level of 12.5 to 14.0 may be preferable. If an optimal preload does not increase cardiac output to normal or higher levels, inotropic agents should be used. If shock still persists, one must be sure that the arterial pH is not excessively high or low. Glucocorticoids may then be given in low dose (200 mg hydrocortisone) in case some degree of adrenal insufficiency is present. They can also be given in high doses (equivalent to 150 mg/kg hydrocortisone) early in septic shock primarily to prevent excess complement activation and to preserve membrane integrity. Vasopressors may occasionally be required if there is excessive vasodilation, especially if there is persistent hypotension in the presence of high-grade coronary or cerebral artery stenosis. Vasodilators may be used to try to correct myocardial ischemia (nitroglycerin), excessive preload (nitroglycerin), or excessive afterload (nitroprusside or hydralazine). Combinations of vasodilators and inotropic agents may be required in some patients with high systemic vascular resistance and persistently low cardiac outputs. Mechanical assist with IABP can be of great value in persistent cardiogenic shock. Diuretics may occasionally help prevent renal failure in patients who are persistently oliguric after blood flow and pressure are restored. Heparin is occasionally of value if DIC develops with no concomitant fibrinolysis. Antibiotics are important in septic shock and may also be important if persistent shock has reduced gastrointestinal mucosal integrity so that bacteria and bacterial products can enter the portal system.(ABSTRACT TRUNCATED AT 400 WORDS)

Intravenous Injection in Wound Shock

Critical parameters in drug delivery by intravenous infusion

Science and shock: a clinical perspective

The treatment of wounds during World War I

Infection in conflict wounded

Ventricular Wall Biomaterial Injection Therapy after Myocardial Infarction: Advances in Material Design, Mechanistic Insight and Early Clinical Experiences

A technique of anaesthesia in haemorrhagic shock. Illustrative case histories and a discussion

Dakin's Solution: "One of the most important and far-reaching contributions to the armamentarium of the surgeons"

A Primer on the Acute Management of Intravenous Extravasation Injuries for the Plastic Surgeon

Hemorrhage Control: Lessons Learned From the Battlefield Use of Hemostatic Agents That Can Be Applied in a Hospital Setting

Progress in injectable hydrogels for the treatment of incompressible bleeding: an update

Autologous Blood in the Treatment of Intraoperative Hemorrhage

Haemodynamic Resuscitation Following Traumatic Haemorrhagic Shock: An Overview

A narrative review of prehospital hemorrhagic shock treatment with non-blood product medications

State of the art, trends, hotspots, and prospects of injection materials for controlling bleeding

Resuscitation for injured patients requiring massive transfusion: A personal perspective

[The bowel as an ischemic organ]

When in Doubt, Pull the Catheter Out: Implementation of an Evidence-Based Protocol in the Prevention and Management of Peripheral Intravenous Infiltration/Extravasation in Neonates

Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding

Science of Wound Healing and Dressing Materials

A career in solving clinical‐pathological conundrums: Heyde syndrome, anti‐platelet factor 4 disorders, and microvascular limb ischemic necrosis